Yi Ba
Impact in
-
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Cell death mechanisms and regulation
Papers in
-
- MicroRNA in disease regulation 3
- Oncology 4
- Cancer Immunotherapy and Biomarkers 1
- Cancer survivorship and care 1
- Co-authors
- Haiyang Zhang (7 shared papers)Ting Deng (5 shared papers)Guoguang Ying (5 shared papers)Shaohua Ge (3 shared papers)He Zhou (1 shared paper)Yunping Luo (1 shared paper)Claudia Chiodoni (1 shared paper)Rong Xiang (1 shared paper)
- Journals
- Cancer Research (2 papers)Tumor Biology (1 paper)Nutrition and Cancer (1 paper)Current Cancer Drug Targets (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Yi Ba
17 papers receiving 647 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 108
- Molecular Biology 380
- Immunology 79
- Biotechnology 20
- Physiology 62
Countries citing papers authored by Yi Ba
This map shows the geographic impact of Yi Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ba more than expected).
Fields of papers citing papers by Yi Ba
This network shows the impact of papers produced by Yi Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ba. The network helps show where Yi Ba may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Ba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 139 | |
| 2 | 2018 | 110 | |
| 3 | 2007 | 92 | |
| 4 | 2021 | 92 | |
| 5 | 2019 | 56 | |
| 6 | 2021 | 55 | |
| 7 | 2018 | 51 | |
| 8 | 2017 | 28 | |
| 9 | 2019 | 12 | |
| 10 | 2021 | 10 | |
| 11 | 2011 | 5 | |
| 12 | Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer | 2020 | 2 |
| 13 | 2024 | 2 | |
| 14 | MIG(CXCL9)ケモカイン遺伝子療法と抗体-サイトカイン融合蛋白質の併用はマウス結腸癌の増殖と播種を抑制する | 2001 | 1 |
| 15 | 2022 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2021 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Yi Ba
Yi Ba is a scholar working on Cancer Research, Oncology, Molecular Biology, Hepatology and Pharmacology, having authored 20 papers that have together received 658 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (4 papers), MicroRNA in disease regulation (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), RNA Interference and Gene Delivery (1 paper), Cancer therapeutics and mechanisms (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Cancer survivorship and care (1 paper). The work is most often cited by research in Cancer Research (108 citations), Molecular Biology (380 citations), Immunology (79 citations), Biotechnology (20 citations) and Physiology (62 citations). Yi Ba has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Haiyang Zhang, Ting Deng, Guoguang Ying, Shaohua Ge, He Zhou, Yunping Luo, Claudia Chiodoni, Rong Xiang, Jürgen Christian Becker and Noriko Mizutani. Their work appears in journals such as Cancer Research, Tumor Biology, Nutrition and Cancer, Current Cancer Drug Targets and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.